Binding characteristics and analgesic activity of D-Ala2-Leu5-enkephalin chloromethyl ketone

Mária Szücs, Sándor Benyhe, Anna Borsodi, Mária Wollemann, Gábor Jancsó, Judit Szécsi, Kálmán Medzihradszky

Research output: Contribution to journalArticle

20 Citations (Scopus)


The chloromethyl ketone derivative of D-Ala2-Leu5-enkephalin (DALECK) was synthesized and its potency was tested in competing for 3H-naloxone binding sites and inducing analgesia. It was established that the compound is a potent affinity reagent at alkaline pH, blocking selectively and irreversibly the high-affinity (KD<1 nM) binding site. Intracisternally given DALECK showed a long-lasting, dose-dependent antinociceptive effect in the rat tail-withdrawal test. This could be completely antagonized by naloxone administration showing the reversible nature of DALECK in this in vivo assay. It is suggested that DALECK binds reversibly to the morphine receptor which mediates analgesia but irreversibly to the enkephalin receptor, the function of which remains to be elucidated.

Original languageEnglish
Pages (from-to)2777-2784
Number of pages8
JournalLife Sciences
Issue number24
Publication statusPublished - Jun 13 1983

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Binding characteristics and analgesic activity of D-Ala<sup>2</sup>-Leu<sup>5</sup>-enkephalin chloromethyl ketone'. Together they form a unique fingerprint.

  • Cite this